Emend for Injection and Insulin aspart, recombinant Subcutaneous
Determining the interaction of Emend for Injection and Insulin aspart, recombinant Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: fosaprepitant
Brand name: Emend for Injection
Synonyms: n.a.
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: Insulin aspart, Insulin Aspart
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Emend for Injection-Insulin degludec
- Emend for Injection-Insulin Degludec (U-100) Prefilled Pens
- Emend for Injection-Insulin Degludec (U-100) Vials
- Emend for Injection-Insulin Degludec (U-200) Prefilled Pens
- Emend for Injection-Insulin degludec and liraglutide
- Emend for Injection-Insulin degludec and liraglutide Subcutaneous
- Insulin aspart, recombinant Subcutaneous-Emend Intravenous
- Insulin aspart, recombinant Subcutaneous-Emflaza
- Insulin aspart, recombinant Subcutaneous-Emflaza (Deflazacort Oral Suspension)
- Insulin aspart, recombinant Subcutaneous-Emflaza (Deflazacort Tablets)
- Insulin aspart, recombinant Subcutaneous-Emicizumab
- Insulin aspart, recombinant Subcutaneous-Emicizumab-kxwh